Skip to content
DataLookout
Menu

RAONCT07371598

Royal Ancient Oats™ Study

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Jun 30, 2026 to Jun 30, 2027 Show 5 more changesShow less
    • Eligibility criteria expanded, about 15 words
    • Study completion pushed from Sep 15, 2026 to Sep 15, 2027
    • Secondary endpoints: details revised at 4 of 5 entries
    • Study description revised
    • Publications: details revised at 12 of 14 entries
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

To compare the effect of consuming high avenanthramide Royal Ancient Oats™ muffins or conventional oat muffins versus white wheat flour muffins on postprandial glycemic response.
Timeframe: 2 weeks

Secondary (1)

To evaluate the effect of Royal Ancient Oats™ on incretin hormone secretion and satiety hormones.

Arms and interventions

A: Order of receiving muffins differsExperimental

A: Order of receiving muffins differs

B: Order of receiving muffins differsExperimental

B: Order of receiving muffins differs

Dietary supplements: Royal Ancient Oat Flour™

Sites

1 site in 1 country

  • Standard Process Nutrition Innovation CenterKannapolis, North Carolina, United States